1. Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study

   • Cary A. Presant
   • Joth Jacobson
   • John S. Macdonald

   OriginalPaper Pages: 369 - 376

2. Phase I Study of Eniluracil, Oral 5-Fluororacil and Gemcitabine in Patients with Advanced Malignancy

   • Sherry Morgan-Meadows
   • James P. Thomas
   • George Wilding

   OriginalPaper Pages: 377 - 382

3. Phase I Escalation of Gemcitabine Combined with Protracted Oral Etoposide in Gynecologic Malignancies – A Gynecologic Oncology Group Study

   • Agustin A. Garcia
   • Michael A. Bookman
   • Katherine Y. Look

   OriginalPaper Pages: 383 - 387

4. A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma

   • David R. Minor
   • Dana Monroe
   • Laurence Elias

   OriginalPaper Pages: 389 - 393

5. Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse

   • Mark S. Berger
   • Lance H. Leopold
   • Matthew L. Sherman

   OriginalPaper Pages: 395 - 406

6. A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study

   • R.G. Tozer
   • S. Burdette-Radoux
   • L. Seymour

   OriginalPaper Pages: 407 - 412

7. Irofulven, a Novel Inhibitor of DNA Synthesis, in Metastatic Renal Cell Cancer

   • Robert J. Amato
   • Cherie Perez
   • Lance Pagliaro

   OriginalPaper Pages: 413 - 417

8. Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer

   • Cynthia G. Leichman
   • Kari Chansky
   • James L. Abbruzzese

   OriginalPaper Pages: 419 - 424

9. Piritrexim in Advanced, Refractory Carcinoma of the Urothelium (E3896): A Phase II Trial of the Eastern Cooperative Oncology Group

   • Bruce J. Roth
   • Judith Manola
   • George Wilding

   OriginalPaper Pages: 425 - 429

10. Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group

    • Ian Quirt
    • Audley Bodurtha
    • Elizabeth Eisenhauer

    OriginalPaper Pages: 431 - 437

11. Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer

    • Maximiliano Van Kooten
    • Moisés Rosenberg
    • Reinaldo D. Chacón

    OriginalPaper Pages: 439 - 446

12. Announcement

    Announcement Pages: 447 - 447

13. Volume Contents

    Volume Contents Pages: 449 - 452

14. Author Index

    Authors Index Pages: 453 - 454

15. Instructions for Authors

    Instructions for Authors Pages: 455 - 459